Role of Everolimus in Highly Sensitized Patients
Clinical trial NCT01911546 · COMPLETED
Trial details
- NCT number
- NCT01911546
- Sponsor
- Joseph Kahwaji, MD, MPH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2016-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.